HomeCompareSCTC vs JNJ

SCTC vs JNJ: Dividend Comparison 2026

SCTC yields 74.07% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCTC wins by $1.25M in total portfolio value
10 years
SCTC
SCTC
● Live price
74.07%
Share price
$2.70
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.27M
Annual income
$347,213.33
Full SCTC calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SCTC vs JNJ

📍 SCTC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCTCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCTC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCTC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCTC
Annual income on $10K today (after 15% tax)
$6,296.30/yr
After 10yr DRIP, annual income (after tax)
$295,131.33/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SCTC beats the other by $294,427.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCTC + JNJ for your $10,000?

SCTC: 50%JNJ: 50%
100% JNJ50/50100% SCTC
Portfolio after 10yr
$644.7K
Annual income
$174,020.55/yr
Blended yield
26.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SCTC
No analyst data
Altman Z
1.3
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCTC buys
0
JNJ buys
0
No recent congressional trades found for SCTC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCTCJNJ
Forward yield74.07%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$1.27M$20.0K
Annual income after 10y$347,213.33$827.78
Total dividends collected$1.09M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SCTC vs JNJ ($10,000, DRIP)

YearSCTC PortfolioSCTC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$18,107$7,407.41$10,676$355.77+$7.4KSCTC
2$31,910$12,535.42$11,407$389.39+$20.5KSCTC
3$54,790$20,645.72$12,198$426.53+$42.6KSCTC
4$91,755$33,129.47$13,056$467.62+$78.7KSCTC
5$150,029$51,851.19$13,987$513.12+$136.0KSCTC
6$239,766$79,235.77$14,998$563.56+$224.8KSCTC
7$374,895$118,345.50$16,098$619.52+$358.8KSCTC
8$574,076$172,937.82$17,295$681.69+$556.8KSCTC
9$861,756$247,494.40$18,599$750.82+$843.2KSCTC
10$1,269,292$347,213.33$20,022$827.78+$1.25MSCTC

SCTC vs JNJ: Complete Analysis 2026

SCTCStock

ScoutCam Inc. develops, manufactures, and markets visual solutions composed of imaging equipment, cloud and software-based image processing, and algorithm methodologies in Israel, the United States, the United Kingdom, and internationally. The company, through its visualization technology offers solutions across predictive maintenance and condition-based monitoring markets in various sectors, such as medical, defense, energy, automotive, aviation, maritime, and industrial non-destructing-testing. Its solutions are based on resilient cameras, specialized AI analysis, and supplementary technologies. The company was founded in 2019 and is based in Omer, Israel.

Full SCTC Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SCTC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCTC vs SCHDSCTC vs JEPISCTC vs OSCTC vs KOSCTC vs MAINSCTC vs ABBVSCTC vs MRKSCTC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.